Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Chimeric Antigen Receptor T-Cell Therapy
Chimeric Antigen Receptor (CAR) T-cell therapy represents a paradigm shift in cancer immunotherapy, offering a highly targeted approach for treating hematological malignancies and solid tumors. This therapy involves genetically engineering a patient’s T-cells to express specific CARs, enabling them to recognize and eliminate tumor cells with ... Read More»
: Current Trends Gynecol Oncol 2024, 9:232
10.4172/ctgo.1000232Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals